Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Demant AS's share price for the quarter that ended in Dec. 2025 was €28.6. Demant AS's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 211 Mil. Therefore, Demant AS's market cap for the quarter that ended in Dec. 2025 was €6,032 Mil.
Demant AS's quarterly market cap
stayed the same
from Dec. 2024 (€7,536 Mil) to Jun. 2025 (€7,536 Mil) but then
declined
from Jun. 2025 (€7,536 Mil) to Dec. 2025 (€6,032 Mil).
Demant AS's annual market cap
declined
from Dec. 2023 (€8,752 Mil) to Dec. 2024 (€7,536 Mil) and
declined
from Dec. 2024 (€7,536 Mil) to Dec. 2025 (€6,032 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Demant AS's Enterprise Value for Today is €10,081 Mil.
Demant AS (WBO:DEMA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Demant AS Market Cap Related Terms
Demant AS Market Cap Historical Data
* Premium members only.
The historical data trend for Demant AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Demant AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Demant AS Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Market Cap distribution charts can be found below:
* The bar in red indicates where Demant AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Demant AS's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Demant AS (WBO:DEMA) has a Market Cap of €7,447 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Demant AS and its competitors. According to the industry distribution chart, Demant AS ranks #40 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 4.6%.
Is Demant AS's Market Cap too high?
Demant AS's current Market Cap is €7,447 Mil. Based on the distribution chart, Demant AS ranks #40 out of 867 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Demant AS has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Demant AS's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Demant AS ranks #40 out of 867 companies for Market Cap. This places Demant AS in the top 5% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Demant AS and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current Market Cap is €7,447 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Demant AS (WBO:DEMA) has a current Market Cap of €7,447 Mil. The stock's GF Value™ is €42.05, compared to a current price of €35.48 — trading 15.6% below its estimated fair value. The current Market Cap is €7,447 Mil. Demant AS's overall GF Score™ is 97/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Demant AS (WBO:DEMA), the current Market Cap is €7,447 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Demant AS (WBO:DEMA) Overvalued in 2026?
Based on GuruFocus' analysis, Demant AS stock appears to be undervalued.
The current stock price of €35.48 is trading 15.6% below its estimated GF Value™ of €42.05.
Key valuation signals for WBO:DEMA:
Market Cap: €7,447 Mil
GF Value™: €42.05 vs. price of €35.48 (15.6% below fair value)
No single metric tells the full story. See the WBO:DEMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
97GF Score
Get the complete analysis for WBO:DEMA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:DEMA has been successfully added to your 
